These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6174653)

  • 41. Antitumor effect of lipiodolized doxorubicin on VX2 carcinoma in rabbits.
    Furuta T; Kanematsu T; Ezaki T; Sugimachi K; Inokuchi K
    Jpn J Surg; 1985 Jan; 15(1):89-91. PubMed ID: 2985855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of endoscopic pirarubicin-Lipiodol emulsion injection therapy for gastric cancer].
    Yoshimura K; Nunomura M; Takiguchi N; Oda K; Suzuki H; Furukawa R; Sarashina H; Kohda K; Saito N; Sugaya Y; Tiku T; Wakathuki K; Ishikawa H; Yasutomi J; Nakajima N
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1519-22. PubMed ID: 8854795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. INTRALYMPHATIC THERAPY FOR LYMPH NODE METASTASES OF CARCINOMA OF THE CERVIX. AN ANALYSIS OF THE PROPOSITION AND PRESENTATION OF PERTINENT EXPERIMENTAL DATA.
    FISCHER HW
    Cancer; 1965 Sep; 18():1059-65. PubMed ID: 14332532
    [No Abstract]   [Full Text] [Related]  

  • 44. [EXPERIMENTAL STUDY OF THE TOXICITY OF ULTRA-FLUID LIPIODOL BY INTRAVENOUS OR LYMPHATIC ROUTE].
    GUERBET M
    J Radiol Electrol Med Nucl; 1964 Dec; 45():887-9. PubMed ID: 14269632
    [No Abstract]   [Full Text] [Related]  

  • 45. [Endolymphatic radiotherapy in cancer of the cervix (author's transl)].
    Luciani L; Musumeci R; De Palo GM; Mattavelli F; Punzi A
    Tumori; 1973; 59(6):389-400. PubMed ID: 4364756
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on antitumor activities of bleomycin oil suspension in vivo (author's transl)].
    Abe F; Ichoda Y; Yamashita T; Yamaguchi S; Yoshioka O
    Jpn J Antibiot; 1976 Sep; 29(9):834-40. PubMed ID: 61292
    [No Abstract]   [Full Text] [Related]  

  • 47. [Experimental studies on chemotherapy in the nude mouse model of squamous cell carcinoma of the mouth].
    Fröhlich M; Henke E; Arnold W; Gens J; Naudorf H
    Dtsch Z Mund Kiefer Gesichtschir; 1984; 8(6):428-32. PubMed ID: 6085295
    [No Abstract]   [Full Text] [Related]  

  • 48. [Behavior of pulmonary radioactivity in patients exposed to endolymphatic radiotherapy with lipiodol F-I 131].
    Bagliani G; Buraggi GL; De Vecchi A; Fava G
    Tumori; 1967; 53(3):225-35. PubMed ID: 4293146
    [No Abstract]   [Full Text] [Related]  

  • 49. [Examination of supraclavicular lymph nodes during lymphography from lower extremities (author's transl)].
    Garcarek J; Hirnle Z; Perek K
    Pol Przegl Radiol Med Nukl; 1979; 43(2):95-7. PubMed ID: 221893
    [No Abstract]   [Full Text] [Related]  

  • 50. Chronic toxicity study in dogs following intralymphatic injections of ethiodol, ethiodol with chlorophyll and sterile non-iodinized poppy seed oil.
    Viamonte M; Soto M; Recher L
    Ind Med Surg; 1966 Aug; 35(8):688-95. PubMed ID: 4288250
    [No Abstract]   [Full Text] [Related]  

  • 51. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 52. [Lymphography and endolymphatic chemotherapy in malignant tumours (author's transl)].
    Miroljubov NN; Laletin VG
    Radiol Diagn (Berl); 1976 Dec; 17(6):827-32. PubMed ID: 190639
    [No Abstract]   [Full Text] [Related]  

  • 53. Experimental study on trans-nodal cancer chemotherapy for metastatic lymph nodes.
    Natsuda Y; Sugimachi K; Ueo H; Matsuzaki K; Inokuchi K; Nakamura T
    Jpn J Surg; 1983 Jul; 13(4):368-72. PubMed ID: 6196508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 57Co-bleomycin kinetics in normal and tumour-bearing mice after systemic and local administration.
    Bier J; Benders P; Bitter K; Wenzel M
    J Maxillofac Surg; 1979 Feb; 7(1):32-40. PubMed ID: 86593
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Tissue levels of bleomycin administered as suppository].
    Okado M; Matsumoto Y; Hamada Y; Yamamoto R; Hidaka R; Yamaoka K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1025-30. PubMed ID: 6191707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Morphology of peripheral lymphatic vessels--a review (author's transl)].
    Mori K
    Kaibogaku Zasshi; 1979 Feb; 54(1):1-20. PubMed ID: 375660
    [No Abstract]   [Full Text] [Related]  

  • 57. [Absorption, excretion, distribution and metabolism of 3H-labelled pepleomycin sulfate (author's transl)].
    Takayama H; Itoh M; Mizuguchi S; Abuki H; Ishibashi M; Miyazaki H
    Jpn J Antibiot; 1978 Dec; 31(12):895-909. PubMed ID: 83412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tissue tolerance to pelvic intraarterial chemoembolization with cisplatin-lipiodol suspension.
    Li J; Zhao YN; Miao ZJ; Zhu L; Wang ZM; Qin HY; Xi JH
    Gynecol Oncol; 1993 Jul; 50(1):10-4. PubMed ID: 8394274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Mode of lymphatic metastasis in the esophageal cancer using VX2 carcinoma in rabbits (author's transl)].
    Nakamura T; Mine H; Okudaira Y; Yaita A; Sugimachi K; Ueo H; Natsuda Y; Inokuchi K
    Nihon Kyobu Geka Gakkai Zasshi; 1978 Jun; 26(6):656-62. PubMed ID: 712128
    [No Abstract]   [Full Text] [Related]  

  • 60. Distribution pattern of radioactive labelled lipiodol-UF following intralymphatic application for therapy.
    Weissleder H; Pfannenstiel P; Peters PE
    Lymphology; 1976 Sep; 9(3):122-6. PubMed ID: 187879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.